908 Devices Inc. (MASS)
About 908 Devices Inc.
908 Devices Inc develops a suite of purpose-built handheld devices for point-of-need chemical analysis. Leveraging mass spectrometry, optical spectroscopy, analytics and machine learning technologies, the company makes devices that are smaller and more accessible than conventional laboratory instruments. Its devices, including MX908, ThreatID, XplorIR and VipIR, are used to analyze unknown materials and provide actionable answers in health, safety and defense technology applications, addressing the fentanyl and illicit drug crisis, toxic carcinogen exposure and security threats. The company reimagines mass spectrometry technology by developing smaller, lower-cost and simpler-to-operate devices compared to conventional instruments, and generates maximum revenue from the United States.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $56.2M
- Net income
- $19.5M
- Total assets
- $190.1M
- Market cap
- $299.9M
- Gross margin
- 50.6%
- Operating margin
- -70.1%
- Net margin
- 34.7%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $56.2M
- Cost of revenue
- $27.8M
- Gross profit
- $28.4M
- Operating expenses
- $67.8M
- Operating income
- -$39.4M
- Income tax
- -$66.0K
- Net income
- $19.5M
- EPS (basic)
- $0.54
- EPS (diluted)
- $0.54
Balance sheet
- Total assets
- $190.1M
- Current assets
- $144.6M
- Total liabilities
- $46.4M
- Current liabilities
- $34.1M
- Shareholders’ equity
- $143.7M
Cash flow
- Operating cash flow
- -$23.7M
- Investing cash flow
- $50.7M
- Financing cash flow
- -$697.0K
- Net cash flow
- $26.4M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $299.9M
- P/E ratio
- 13.2
- EPS (diluted)
- $0.54
- Shares outstanding
- 42.0M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Dec 18, 2020
908 Devices Inc. (MASS) Stock Price
- Profitable — net income of $19.5M in FY2025.
- Revenue grew 33% from FY2021 to FY2025.
- Gross margin of 50.6%, net margin 34.7%.
- Trading 22% below its 52-week high.
- Valued at a price-to-earnings (P/E) ratio of 13.2.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review 908 Devices Inc..
Write a review
News about 908 Devices Inc.
News & sentiment via Polygon.io
908 Devices Inc.: frequently asked questions
Is 908 Devices Inc. an American company?
908 Devices Inc. is a US-based company headquartered in Burlington, Massachusetts, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is 908 Devices Inc. headquartered?
908 Devices Inc. is headquartered in Burlington, Massachusetts, United States.
Is 908 Devices Inc. publicly traded?
Yes — 908 Devices Inc. is a publicly traded company. Its stock trades under the ticker symbol MASS on the NASDAQ.
What does 908 Devices Inc. do?
908 Devices Inc. is an American Medical Devices company in the Health & Beauty sector.
